Promotions & Moves

Integer Announces CEO Succession Plan

Payman Khales is appointed CEO as Joseph Dziedzic will retire.

By: Rachel Klemovitch

Assistant Editor

Integer Holdings Corporation, a medical device contract development and manufacturing organization, announced that Joseph Dziedzic will retire as President and Chief Executive Officer and will step down from the Board of Directors, effective October 24, 2025.  Payman Khales, Chief Operating Officer, will assume the President and CEO position and join the company’s Board of Directors. For a smooth transition, Dziedzic will serve as an advisor to the company through March 31, 2026. “We are i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters